Johnson & Johnson reaffirmed earnings outlook for the year 2015. For the period, the company expects sales of $70 billion to $71 billion, and adjusted earnings for the full-year 2015 of $6.15 to $6.20 per share, which excludes special items such as restructuring charges.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.6 USD | +3.69% | +4.78% | -0.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.10% | 38TCr | |
+55.35% | 82TCr | |
+32.62% | 60TCr | |
+15.47% | 32TCr | |
+13.10% | 31TCr | |
+16.36% | 25TCr | |
+14.80% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr | |
+3.06% | 13TCr |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Reaffirms Earnings Outlook for the Year 2015